Head Office

Trillium Therapeutics Inc.
2488 Dunwin Drive
Mississauga, Ontario,
Canada L5L 1J9
Tel: +1 416.595.0627

Investor Relations Contact

Jason Wong
Blueprint Life Science Group for Trillium Therapeutics
Tel: +1 415.375.3340 x4
jwong@bplifescience.com

Media Relations Contact

Jessica Tieszen
Canale Communications for Trillium Therapeutics
Tel: +1 619.849.5385
jessica@canalecomm.com

Registered Shareholders

If you are currently a registered shareholder and would like to change your address or request information regarding share certificates or stock transfers, please contact our transfer agent in writing, by phone or fax at:

Computershare Investor Services Inc.
100 University Ave, 8th Floor
Toronto, On, M5J 2Y1

Toll free in North America
Phone: +1 800.564.6253
Fax: +1 866.249.7555

International
Phone: +1 514.982.7555
Fax: +1 416.263.9524

Or access Computershare on the web at Computershare.com and log into the Investor Centre.

Beneficial Shareholders

If you are a beneficial shareholder (your shares are held by your broker in name of a brokerage house), questions should be directed to your broker on administrative matters. If you would like to receive quarterly reports, please write to or call Computershare Investor Services Inc. with your name and address, or access Computershare on the web at Computershare.com and log into the Investor Centre.

Careers

Trillium Therapeutics is looking for talented individuals to join our team.

Please send your cover letter and resume or any position enquiries to careers@trilliumtherapeutics.com and include the position of interest in the subject line of your e-mail.

Current Opportunities

There are currently no openings at this time.

Life at Trillium

At Trillium, employees work in an enriching environment that promotes team building, mutual respect and fairness. Our commitment to fighting cancer begins in our laboratories and board rooms but extends to our community at large with participation in events such as Rexall’s OneWalk to Conquer Cancer to raise funds for Princess Margaret Cancer Centre.